CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects

Claudia Barassi(Vita-Salute San Raffaele University), Lucia Lopalco(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University)

Blood

September 17, 2004

10.1182/blood-2004-06-2134

Cited by 42

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia

|New England Journal of Medicine|2003|653

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

|The Lancet|2009|620

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

|Clinical Microbiology and Infection|2020|391

Control of HIV despite the Discontinuation of Antiretroviral Therapy

|New England Journal of Medicine|1999|328

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

|Immunity|2011|285